The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
Open accessAbstract
The selective serotonin reuptake inhibitors (SSRIs) are considered the first-line pharmacological treatment for PTSD. However, even when treated with this class of drugs, response rates rarely exceed 60% and less than 20-30% of the patients achieve full remission. The aim of this study was to address this limitation by systematically reviewing the options left for the treatment of PTSD when patients do not respond satisfactorily to or tolerate SSRIs. A systematic review covering all original articles, letters and brief reports published in any language until October 2008 was conducted through searches in the ISI/Web of Science, PubMed and PILOTS databases. The search terms included the pharmacological class of each agent or its generic name plus "PTSD" or "stress disorder" in the title, in the abstract or as a keyword. Sixty-three articles were selected, covering the following categories: antipsychotics, anticonvulsants, adrenergic-inhibiting agents, opioid antagonists, benzodiazepines and other agents. None of the identified agents reached the level A of scientific evidence, 5 reached level B, 7 level C and 13 level D. The non-antidepressant agent with the strongest scientific evidence supporting its use in PTSD is risperidone, which can be envisaged as an effective add-on therapy when patients did not fully benefit from previous treatment with SSRIs. Prazosin, an adrenergic-inhibiting agent, is a promising alternative for cases of PTSD where nightmares and insomnia are prominent symptoms. So far, there is no consistent empirical support for using benzodiazepines in the prevention or in the treatment of PTSD, although these drugs could alleviate some associated non-specific symptoms, such as insomnia or anxiety. Further controlled clinical trials and meta-analysis are needed to guide clinicians in their search of effective pharmacological alternatives to antidepressants in PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“because 20–30% of PTSD patients do not respond at all to treatment with the current gold standard of PTSD drug therapy, the serotonin re-uptake inhibitors [7].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379
(1976) · Medical Entomology and Zoology · Cited by 8,899
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70990-1_10 · Cited by 3,074
Reliability and validity of a brief instrument for assessing post-traumatic stress disorder
Foa, E. B., Riggs, D. S., Dancu, C. V., & Rothbaum, B. O. (1993) · Journal of Traumatic Stress · doi:10.1002/jts.2490060405 · Cited by 2,537
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Amygdala, medial prefrontal cortex, and hippocampal function in PTSD
SHIN, L. M., RAUCH, S. L., & PITMAN, R. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.007 · Cited by 1,203
Research works printed but not linked: 1
- Forster, 1995, Lithium for irritability in posttraumatic-stress-disorder, J Trauma Stress, 8, 143, 10.1002/jts.2490080110 · DOI
Cited by
Sorted by citations
Items 101–200 of 347
Campos, B., Vinder, V., Passos, R. B. F., Coutinho, E. S. F., Vieira, N. C. P., Leal, K. B., Mendlowicz, M. V., Figueira, I., Luz, M. P., Marques-Portela, C., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221080464 · Cited by 31
Self-citationPeng, Z., Zhang, R., Wang, H., Chen, Y., Xue, F., Wang, L., Yang, F., Chen, Y., Liu, L., Kuang, F., et al. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.032 · Cited by 30
Ahmadi, K., Hazrati, M., Ahmadizadeh, M., & Noohi, S. (2015) · Acta medica Indonesiana · Cited by 27
Song, D., Ge, Y., Chen, Z., Shang, C., Guo, Y., Zhao, T.-Y., Li, Y., Wu, N., Song, R., & Li, J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.001 · Cited by 27
Araújo, A. X., Berger, W., Coutinho, E., Marques-Portella, C., Luz, M. P., Cabizuca, M., Fiszman, A., Figueira, I., & Mendlowicz, M. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.09.004 · Cited by 36
Self-citationBarnes, V. A., Monto, A., Williams, J. J., & Rigg, J. L. (2016) · Military Medicine · doi:10.7205/milmed-d-14-00333 · Cited by 27
Medical best practices for the treatment of torture survivors.
Mollica, R. F. (2011) · PubMed · Cited by 27
Risbrough, V. B., Glenn, D. E., & Baker, D. G. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5010 · Cited by 28
Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin
Simon, P. Y. R., & Rousseau, P. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659275 · Cited by 26
Augmenting the Treatment of PTSD with Ketamine—a Review
Duek, O. A., Kelmendi, B., Pietrzak, R. H., & Harpaz‐Rotem, I. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-00172-0 · Cited by 24
Lake, J. (2015) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2014.10.002 · Cited by 27
Bauer, M. S., Lee, A. F., Li, M., Bajor, L., Rasmusson, A. M., & Kazis, L. E. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3507 · Cited by 26
The role of Ect in Posttraumatic Stress Disorder: A Systematic Review
Youssef, N. A., McCall, W. V., & Andrade, C. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900111 · Cited by 25
Gasparyan, A., Navarrete, F., & Manzanares, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.694510 · Cited by 25
VanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 28
Psychopharmacological treatment for military posttraumatic stress disorder: An integrative review
Tawa, J., & Murphy, S. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1111/1745-7599.12016 · Cited by 28
Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
Steardo, L., Carbone, E. A., Menculini, G., Moretti, P., Steardo, L., & Tortorella, A. A. V. (2021) · Life · doi:10.3390/life11030214 · Cited by 24
The South African Society of Psychiatrists (SASOP) Treatment Guidlelines for Psychiatric Disorders
Emsley, R. A., Flisher, A. J., Grobler, G. P., Seedat, S., & Szabo, C. P. (2013) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v19i3.942 · Cited by 25
Sweeten, B. L. W., Sutton, A. M., Wellman, L. L., & Sanford, L. D. (2019) · SLEEP · doi:10.1093/sleep/zsz199 · Cited by 25
Bandelow, B., Koch, M., Zimmermann, P. L., Biesold, K.-H., Wedekind, D., & Falkai, P. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0289-8 · Cited by 25
Xie, G., Gao, X., Guo, Q., Liang, H., Yao, L., Li, W., Ma, B., Wu, N., Han, X., & Li, J. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.016 · Cited by 23
Sarapultsev, A., Komelkova, M. V., Lookin, O. N., Khatsko, S. L., Gusev, E., Трофимов, А. Н., Tokay, T., & Hu, D. (2024) · Pathophysiology · doi:10.3390/pathophysiology31040051 · Cited by 23
Medical cannabis for treatment-resistant combat PTSD
Nacasch, N., Avni, C., & Toren, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1014630 · Cited by 23
Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16017 · Cited by 24
Rogala, B., Li, Y., Li, S., Chen, X., & Kirouac, G. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049669 · Cited by 23
Treatments of Posttraumatic Stress Disorder in Civilian Populations
Grasser, L. R., & Javanbakht, A. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0994-3 · Cited by 24
Almeida, T. M., da Silva, U. R. L., Pires, J. P., Borges, I. N., Martins, C. R. M., Cordeiro, Q., & Uchida, R. R. (2024) · PubMed Central · doi:10.36131/cnfioritieditore20240102 · Cited by 35
Mekawi, Y., Murphy, L. M., Munoz, A. P., Briscione, M. A., Tone, E. B., Norrholm, S. D., Jovanović, T., Bradley, B., & Powers, A. D. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112674 · Cited by 22
de Abreu, M. S., Giacomini, A. C. V. V., Genário, R., Rech, N., Carboni, J., Lakstygal, A. M., Amstislavskaya, T. G., Demin, K. A., Leonard, B. E., Vlok, M., et al. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172928 · Cited by 23
Prajapati, S. K., & Krishnamurthy, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-020-00198-9 · Cited by 22
Fine, N. B., Helpman, L., Armon, D. B., Gurevitch, G., Sheppes, G., Seligman, Z., Hendler, T., & Bloch, M. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13591 · Cited by 23
Cai, M., Park, H. R., & Yang, E. J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02663-4 · Cited by 23
Verplaetse, T. L. (2018) · Alcohol research · doi:10.35946/arcr.v39.2.09 · Cited by 22
Pérez, A. D. A., Popik, B., & Alvares, L. D. O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108107 · Cited by 19
Sur, B., & Lee, B. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8320256 · Cited by 21
Janezic, E. M., Uppalapati, S., Nagl, S., Contreras, M., French, E. D., & Fellous, J. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000270 · Cited by 23
Geriatric mental health disaster and emergency preparedness
Toner, J. A., Therese, M., Mierswa, & Howe, J. L. (2010) · Medical Entomology and Zoology · Cited by 20
Sur, B., & Lee, B. (2022) · Journal of Natural Medicines · doi:10.1007/s11418-022-01636-z · Cited by 19
Quetiapine Treatment for Post-traumatic Stress Disorder: A Systematic Review of the Literature
Crapanzano, C., Damiani, S., Casolaro, I., & Amendola, C. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.49 · Cited by 19
Liu, X., Xie, X., Wang, K., & Cui, H. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.027 · Cited by 19
Wang, Z., Zhu, K., Chen, L., Yang, L. O., Huang, Y.-F., & Zhao, Y. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.017 · Cited by 19
Noradrenaline transmission reducing drugs may protect against a broad range of diseases.
Fitzgerald, P. J. (2014) · Autonomic and Autacoid Pharmacology · doi:10.1111/aap.12019 · Cited by 19
Kelmendi, B., Adams, T. G., Southwick, S. M., Abdallah, C. G., & Krystal, J. H. (2017) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12202 · Cited by 20
Schuerbeek, A. V., Vanderhasselt, M., Baeken, C., Pierre, A., Smolders, I. J., Waes, V. V., & Bundel, D. D. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.01.005 · Cited by 22
Defining response and nonresponse to posttraumatic stress disorder treatments: A systematic review.
Varker, T., Kartal, D., Watson, L., Freijah, I., O'Donnell, M. L., Forbes, D., Phelps, A. J., Hopwood, M., McFARLANE, A. C., Cooper, J., et al. (2020) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12355 · Cited by 18
The Neurotransmission Basis of Post-Traumatic Stress Disorders by the Fear Conditioning Paradigm
Traina, G., & Tuszyński, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216327 · Cited by 19
Glenn, D. E., Acheson, D. T., Geyer, M. A., Nievergelt, C. M., Baker, D. G., Risbrough, V. B., & MRS Team (2016) · Depression and Anxiety · doi:10.1002/da.22475 · Cited by 18
Borrelli, J., Starr, A. J., Downs, D. L., & North, C. S. (2018) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001342 · Cited by 18
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21
Rice, O. V., Ashby, C. R., Dixon, C., Laurenzo, W., Hayden, J., Song, R., Li, J., Tiwari, A. K., & Gardner, E. L. (2018) · Synapse · doi:10.1002/syn.22035 · Cited by 17
The Quality, Readability, Completeness, and Accuracy of PTSD Websites for Firefighters
Killip, S. C., Kwong, N. K. R., MacDermid, J. C., Fletcher, A. J., & Carleton, R. N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207629 · Cited by 17
Neuroendocrinological treatment targets for posttraumatic stress disorder
Yoon, S., & Kim, Y. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.021 · Cited by 19
Baig, M. R., Tapia, R. N., Meraj, A., Pugh, J. A., Roache, J. D., & Finley, E. P. (2019) · Psychiatric Quarterly · doi:10.1007/s11126-019-09668-7 · Cited by 16
Liu, Y., Steinhausen, K., Bharwani, A., Mian, M. F., Neufeld, K. M., & Forsythe, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-69968-y · Cited by 16
O'Connor, S. M., Sleebs, B. E., Street, I. P., Flynn, B. L., Baell, J. B., Coles, C., Quazi, N., Paul, D., Poiraud, E., Huyard, B., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109836 · Cited by 15
Richerson, J. T., Wagner, T. H., Abrams, T. E., Skelton, K. H., Biswas, K., Illarmo, S., McSherry, F., Fallon, M. T., Frakt, A. B., Pizer, S. D., et al. (2023) · Psychiatric Services · doi:10.1176/appi.ps.20220138 · Cited by 15
Maier, A., Dharan, A. L., Oliver, G., Berk, M., Redston, S., Back, S. E., Kalivas, P. W., Ng, C. H., & Kanaan, R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02793-9 · Cited by 16
Kondev, V., Morgan, A., Najeed, M., Winters, N. D., Kingsley, P. J., Marnett, L. J., & Patel, S. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.05.012 · Cited by 17
Genome to Phenome: A Systems Biology Approach to PTSD Using an Animal Model
Chakraborty, N., Meyerhoff, J., Jett, M., & Hammamieh, R. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6952-4_6 · Cited by 14
Yacoub, O. N. A., Awwad, H. O., Zhang, Y., & Standifer, K. M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107982 · Cited by 15
Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon
Elsouri, K. N., Kalhori, S., Colunge, D., Grabarczyk, G., Hanna, G., Carrasco, C., Espino, A. A., Francisco, A., Borosky, B., Bekheit, B., et al. (2022) · Cureus · doi:10.7759/cureus.25235 · Cited by 17
Closed-loop brain stimulation augments fear extinction in male rats
Sierra, R. O., Pedraza, L. K., Barcsai, L., Pejin, A., Li, Q., Kozák, G., Takeuchi, Y., Nagy, A. J., Lörincz, M. L., Devinsky, O., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39546-7 · Cited by 16
Kanaan, R., Oliver, G., Dharan, A. L., Sendi, S., Maier, A., Mohebbi, M., Ng, C. H., Back, S. E., Kalivas, P. W., & Berk, M. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115398 · Cited by 15
Coimbra, B. M., Yeh, M. S. L., D'Elia, A. T., Maciel, M. R., Carvalho, C. M., Milani, A. C. C., Mozzambani, A. C. F., Juruena, M. F., Belangero, S. I., Jackowski, A. P., et al. (2020) · JMIR Research Protocols · doi:10.2196/19162 · Cited by 14
Eye Movement Desensitization and Reprocessing for Posttraumatic Stress Disorder in Bipolar Disorder
Oh, D., & Kim, D. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.3.340 · Cited by 13
Kapfhammer, H. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.2/hkapfhammer · Cited by 13
Trastorno por estrés agudo y postraumático
Generelo, T. C., Gutiérrez, L. C., & Ruiz, H. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.07.002 · Cited by 13
A Review of Interventions for Treatment-Resistant Posttraumatic Stress Disorder
Katz, C., Stein, M. B., Don, J., Seedat, S., & Saree, J. (2011) · InTech eBooks · doi:10.5772/23234 · Cited by 13
Feder, A., Costi, S., Rutter, S., Collins, A. B., Govindarajulu, U. S., Jha, M. K., Horn, S. R. G.-V., Kautz, M. M., Corniquel, M., Collins, K. A., et al. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021014 · Cited by 12
Bommaraju, S., Dhokne, M. D., Arun, E. V., Srinivasan, K., Sharma, S. S., & Datusalia, A. K. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110943 · Cited by 12
Melani, M., Paiva, J. M., Silva, M. C., Mendlowicz, M. V., Figueira, I. L. D. V., Marques‐Portella, C., Luz, M. P., Ventura, P. R., & Berger, W. L. (2020) · Depression and Anxiety · doi:10.1002/da.23078 · Cited by 13
Self-citationAschbacher, K., Cole, S. W., Hagan, M. J., Rivera, L. M., Baccarella, A., Wolkowitz, O. M., Lieberman, A. F., & Bush, N. R. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.012 · Cited by 12
Xu, G., Li, G., Yang, Q., Li, C., & Liu, C. (2023) · Stress and Health · doi:10.1002/smi.3292 · Cited by 14
Management of Treatment-Resistant Posttraumatic Stress Disorder
Starke, J., & Stein, D. J. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0130-0 · Cited by 12
Anticonvulsants to treat post‐traumatic stress disorder
Wang, H. R., Woo, Y. S., & Bahk, W. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2425 · Cited by 12
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
Alexander, C., & Vasefi, M. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.08.001 · Cited by 12
Hashikawa‐Hobara, N., Yoneyama, Y., Fujiwara, K., & Hashikawa, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-05518-y · Cited by 11
Repetitive transcranial magnetic stimulation for post-traumatic stress disorder: Lights and shadows
Concerto, C., Lanza, G., Fisicaro, F., Pennisi, M., Rodolico, A., Torrisi, G., Bella, R., & Aguglia, E. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i17.5929 · Cited by 12
Sadeghi, M. A., Hemmati, S., Yousefi‐Manesh, H., Fekrvand, S., Foroutani, L., Nassireslami, E., Zoshk, M. Y., Hosseini, Y., Dehpour, A. R., & Chamanara, M. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114128 · Cited by 11
Sarkar, I., Snippe-Strauss, M., Zamir, A. T., Benhos, A., & Richter‐Levin, G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1071482 · Cited by 10
Evaluation of cage leaving behaviour in rats as a free choice paradigm
Bert, B., Schmidt, N. B., Voigt, J., Fink, H., & Rex, A. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.01.001 · Cited by 11
Kondev, V., Bluett, R. J., Najeed, M., Rosas-Vidal, L. E., Grueter, B. A., & Patel, S. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100510 · Cited by 10
Norred, M. A., Zuschlag, Z. D., & Hamner, M. B. (2024) · Drugs · doi:10.1007/s40265-023-01983-5 · Cited by 13
Shiroma, P. R., THURAS, P. D., Polusny, M. A., Kehle‐Forbes, S., Disner, S. G., Pardo, J. V., Gilmore, C. S., Tolly, B., Voller, E. K., McManus, E. S., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107569 · Cited by 10
Raut, S. B., Joly, F., Haass, N. K., Eri, R. D., Canales, J. J., Benedek, D. M., Ursano, R. J., & Johnson, L. R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03190-6 · Cited by 10
Saggu, S., Chen, Y., Cottingham, C., Rehman, H., Wang, H., Zhang, S., Augelli‐Szafran, C. E., Lu, S., Lambert, N. A., Jiao, K., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01851-w · Cited by 10
Ragnhildstveit, A., Kaiyo, M., Snyder, M. B., Jackson, L. K., Lopez, A., Mayo, C., Miranda, A. C., August, R. J., Seli, P., Robison, R. J., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1051542 · Cited by 10
MARCOLIN, K. A. D. S. F., Cunha, A. B. M., Yoneyama, B. C., & Ribeiro, T. A. (2023) · SAGE Open Medicine · doi:10.1177/20503121231160953 · Cited by 10
Kawano, T., Oshibuchi, H., Kawano, M., Muraoka, H., Tsutsumi, T., Yamada, M., Ishigooka, J., Nishimura, K., & Inada, K. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.048 · Cited by 9
Chen, J., Ye, W., Li, L., Su, J., Huang, Y.-L., Liu, L., Wu, L., & Yan, C. (2020) · PubMed Central · doi:10.22038/ijbms.2020.41214.9738 · Cited by 10
Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats
Zaidi, S., Atrooz, F., Valdez, D., Liu, H., Kochi, C., Bond, R. A., & Salim, S. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134892 · Cited by 10
Rodriguez, K. E., Anderson, L. M., Ott, C. A., & O’Haire, M. E. (2021) · Anthrozoös · doi:10.1080/08927936.2021.1898219 · Cited by 13
Ali, M., Oble, M. J. P., Sonia, S. N., George, S., Shahi, S. R., Ali, Z., Abaza, A., Jamil, A., Gutlapalli, S. D., & Khan, S. (2023) · Cureus · doi:10.7759/cureus.47765 · Cited by 9
Guo, Y., Kang, Y., Bai, W., Liu, Q., Zhang, R., Wang, Y., & Wang, C. (2023) · Environmental Toxicology · doi:10.1002/tox.24007 · Cited by 10
Multi-component Treatment for Posttraumatic Nightmares in Vietnam Veterans: Two Case Studies
Wanner, J. L., Long, M. E., & Teng, E. J. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000386910.31817.b5 · Cited by 9
Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD
Jones, A., Warner‐Schmidt, J. L., Kwak, H., Stogniew, M., Mandell, B., Ching, T. H. W., Stein, M. B., & Kelmendi, B. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.4625 · Cited by 8
The GR-FKBP51 interaction modulates fear memory but not spatial or recognition memory
Jiang, A., Zhou, C., Samsom, J., Yan, S., Yu, D. Z., Jia, Z., Wong, A. H. C., & Liu, F. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110604 · Cited by 8
Sheldon (2014) · Current Research in Psychology · doi:10.3844/crpsp.2014.40.63 · Cited by 8
Schaffer, A., McIntosh, D., Goldstein, B. I., Rector, N. A., McIntyre, R. S., Beaulieu, S., Swinson, R., & Yatham, L. N. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400103 · Cited by 7
Lin, Y., Ma, S., Sun, R., Ruan, M., Zhang, F., & Zhang, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115116 · Cited by 7
Metadata
- Authors
- Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I.
- Affiliations
- Universidade Federal do Rio de Janeiro (BR)
- Cambridge Health Alliance (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Berger, William
- ORCID
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 33
- Issue
- 2
- Pages
- 169-180
- ISSN
- 0278-5846 (ISSN-L)
- PMC
- PMC2720612
- OpenAlex
- W1977428298
- Cited by
- 347
- References
- 137
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 29 · 2023: 26 · 2022: 28 · 2021: 41 · 2020: 27 · 2019: 15 · 2018: 24 · 2017: 12 · 2016: 17 · 2015: 16 · 2014: 16 · 2013: 17 · 2012: 18
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Australian Government
- Governo Brasil
- National Institute of Mental Health (MH056350-06, R01MH056350)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Psychology › Clinical Psychology › Migration, Health and Trauma
- Keywords
- post-traumatic stress disorder, pharmacotherapy, antidepressants, selective serotonin reuptake inhibitors, risperidone, prazosin, benzodiazepines, antipsychotic drugs, antiepileptic drugs, opioid antagonists, treatment-resistant PTSD, nightmares, insomnia, adjunctive therapy
- MeSH terms
- Animals, Anticonvulsants, Antidepressive Agents, Benzodiazepines, Humans, Narcotic Antagonists, Stress Disorders, Post-Traumatic, Antipsychotic Agents, Adrenergic Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review